BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12966934)

  • 41. [Heparin-induced thrombocytopenia].
    Depasse F; Samama MM
    Ann Biol Clin (Paris); 2000; 58(3):317-26. PubMed ID: 10846236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. White Clot Syndrome.
    Mallios A; Jennings W
    Eur J Vasc Endovasc Surg; 2018 Mar; 55(3):404. PubMed ID: 29054794
    [No Abstract]   [Full Text] [Related]  

  • 43. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
    Christiansen S; Jahn UR; Meyer J; Scheld HH; Van Aken H; Kehrel BE; Hammel D
    Ann Thorac Surg; 2000 Mar; 69(3):774-7. PubMed ID: 10750760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
    Hassell K
    Chest; 2005 Feb; 127(2 Suppl):1S-8S. PubMed ID: 15706025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invited commentary.
    Francis JL
    Ann Thorac Surg; 2006 Jul; 82(1):26-7. PubMed ID: 16798181
    [No Abstract]   [Full Text] [Related]  

  • 46. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
    Tardy B; Tardy-Poncet B; Viallon A; Piot M; Mazet E
    Thromb Haemost; 1998 Sep; 80(3):530. PubMed ID: 9759647
    [No Abstract]   [Full Text] [Related]  

  • 47. Management strategies for heparin-induced thrombocytopenia in heart-transplant candidates: case report and review of the literature.
    Pamboukian SV; Ignaszewski AP; Ross HJ
    J Heart Lung Transplant; 2000 Aug; 19(8):810-4. PubMed ID: 10967277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 49. [[Treatment with danaparoid during pregnancy for a woman with a cutenous allergy to low-molecular-weight heparin] ].
    de Saint-Blanquat L; Simon L; Toubas MF; Hamza J
    Ann Fr Anesth Reanim; 2000 Dec; 19(10):751-4. PubMed ID: 11200764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Sinus vein thrombosis. A rare complication of heparin-induced thrombocytopenia type II].
    Merz S; Fehr R; Gülke C
    Anaesthesist; 2004 Jun; 53(6):551-4. PubMed ID: 15146282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heparin-induced thrombocytopenia: how to manage it, how to avoid it.
    Caiola E
    Cleve Clin J Med; 2000 Sep; 67(9):621-4. PubMed ID: 10992619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heparin-induced thrombocytopenia presenting after the cessation of low molecular weight heparin prophylaxis with enoxaparin.
    Barratt SM; Ruff SJ; Edwards RC
    Med J Aust; 2000 May; 172(9):449. PubMed ID: 10870540
    [No Abstract]   [Full Text] [Related]  

  • 53. Two cases of valvular thrombosis secondary to heparin-induced thrombocytopenia managed without surgery.
    Ricome S; Provenchere S; Aubier B; Ajzenberg N; Lepage L; Dilly MP; Dufour G; Montravers P; Longrois D
    Circulation; 2011 Mar; 123(12):1355-7. PubMed ID: 21444894
    [No Abstract]   [Full Text] [Related]  

  • 54. New treatment options for heparin-induced thrombocytopenia.
    Ortel TL; Chong BH
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):26-34; discussion 35-6. PubMed ID: 9855181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid.
    Neuhaus TJ; Goetschel P; Schmugge M; Leumann E
    Pediatr Nephrol; 2000 Aug; 14(8-9):713-6. PubMed ID: 10955913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
    Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Anticoagulants in clinical practice].
    Boneu B
    Rev Prat; 1999 Oct; 49(15):1641-7. PubMed ID: 10581994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.
    Wester JP; Haas FJ; Biesma DH; Leusink JA; Veth G
    Intensive Care Med; 2004 Oct; 30(10):1927-34. PubMed ID: 15156309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of heparin-induced thrombocytopenia.
    Dager WE; White RH
    Ann Pharmacother; 2002 Mar; 36(3):489-503. PubMed ID: 11895064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary artery bypass grafting in a patient with type II heparin associated thrombopenia.
    Christiansen S; Geiger A; Splittgerber FH; Reidemeister JC
    Cardiovasc Surg; 1998 Feb; 6(1):90-3. PubMed ID: 9546852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.